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Abstract
Objective: Increasingly, epidemiologic studies use administrative data to identify atrial fibrillation (AF). Capture of incident
AF is not well documented. We examined incidence rates and concordance of AF diagnosis based on active cohort follow-
up versus surveillance of Centers for Medicare and Medicaid Services data in the Atherosclerosis Risk in Communities study.
Methods: Atherosclerosis Risk in Communities cohort participants without prevalent AF enrolled in fee-for-service Medicare,
with inpatient and outpatient coverage, for at least 12 continuous months between 1991 and 2009 were included. In active
Atherosclerosis Risk in Communities study follow-up, annual telephone calls captured hospitalizations and deaths with
incident AF diagnosis codes. For Centers for Medicare and Medicaid Services data, incident AF was defined by billed
inpatient and outpatient diagnoses.
Results: Of 10,134 eligible cohort participants, 738 developed AF according to both Atherosclerosis Risk in Communities
and Centers for Medicare and Medicaid Services data; an additional 93 and 288 incident cases were identified using only
Atherosclerosis Risk in Communities and Centers for Medicare and Medicaid Services data, respectively. Incidence rates per
1,000 person-years were 10.8 (95% confidence interval: 10.1–11.6) and 13.6 (95% confidence interval: 12.8–14.4) in
Atherosclerosis Risk in Communities and Centers for Medicare and Medicaid Services, respectively; agreement was 96%;
kappa was 0.77 (95% confidence interval: 0.75–0.80). Earlier AF ascertainment by one system versus the other was not
associated with any cardiovascular disease risk factors, after accounting for sociodemographic factors. Additional Centers for
Medicare and Medicaid Services events did not alter observed associations between risk factors and AF.
Conclusion: Among fee-for-service enrollees, AF incidence rates were slightly lower for active cohort follow-up than for
Centers for Medicare and Medicaid Services surveillance, because the latter included outpatient atrial fibrillation.
Concordance was high and combining the two approaches could provide a more complete picture of newly-diagnosed AF.
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Introduction
Increasingly, administrative data are used for research purposes,
including epidemiologic studies to identify patients with cardio-
vascular diseases (CVDs) [1–5] such as atrial fibrillation (AF) [6].
The ability to efficiently and inexpensively access information on a
large number of people makes administrative claims an appealing
source of outcomes for epidemiologic research. However, the
usefulness of this approach varies by numerous factors, including
the disease algorithm chosen and the population studied. Medicare
data are often used but are limited to those $65 and not having
supplemental health maintenance organization (HMO) coverage.
High-performing algorithms have been developed to identify
major CVDs [1–5]. A recent systematic review of algorithms used
to identify AF in administrative data reported a median positive
predictive value (PPV) of 89% (range: 70%–96%) and a median
sensitivity of 79% (range: 57%–95%) [7].
Despite performance measures indicating that administrative
data could be a promising source for identifying AF patients, gaps
exist concerning the appropriateness of this approach. A
systematic review of 16 unique studies found that only one
examined the ability of administrative data to identify incident AF.
In this single study, a physician reviewed a sample of 125 hospital
discharge summaries with a first ICD-9 code for AF and ECGs
performed during that hospitalization to determine the validity of
using hospital discharge codes; the PPV for any AF was 89% and
for incident AF was 62% [8]. No study has compared AF
ascertainment using only inpatient or only outpatient claims
compared to using both types of claims. An important limitation of
some cohort studies, including the Atherosclerosis Risk in
Communities (ARIC) and Cardiovascular Health Study (CHS)
cohorts, is reliance exclusively on inpatient claims to identify AF
[8,9], which could result in under-ascertainment. Furthermore, the
majority of studies were performed in predominately white
populations. The validity of utilizing administrative data may
vary by race/ethnicity, as one study performed a subgroup
analysis among stroke patients and reported a lower sensitivity of
AF ascertainment for blacks compared to whites [8].
We sought to address the problem of limited knowledge
regarding the usefulness of administrative data to identify incident
AF, the lack of inpatient and outpatient claims comparison, and
the paucity of data in nonwhite populations. We compared overall
and race-specific incidence rates of AF using the active ARIC
follow-up method with surveillance of Centers for Medicare and
Medicaid Services (CMS) administrative Medicare claims data
(inpatient only, outpatient only and both inpatient and outpatient
claims). We assessed concordance of AF diagnosis between the
data sources and performed a descriptive analysis to identify
factors associated with earlier diagnosis as well as concordance.
Methods
Ethics statement
The ARIC study has been approved by the Institutional Review
Boards (IRB) of all participating institutions, including the IRBs of
the University of Minnesota, Johns Hopkins University, University
of North Carolina, University of Mississippi Medical Center, and
Wake Forest University. Participants provided written informed
consent during each of the ARIC study visits, including permission
to utilize information derived from their healthcare utilization.
Data sources
The ARIC study is a population-based biracial cohort of 15,792
participants aged 45–64 years at enrollment (1987–1989), from
four communities in North Carolina, Mississippi, Minnesota, and
Maryland [10]. Additional study exams occurred during three
follow-up visits as well as annual telephone contact to obtain
information about all hospitalizations and vital status, details of
which have been reported previously [8].
The ARIC study has an Interagency Agreement with CMS to
obtain Medicare data for ARIC cohort participants. Participants
are matched on social security number, sex, and date of birth. Of
the 15,738 ARIC participants alive on January 1, 1991, 14,530
(92.3%) were matched successfully and linked to CMS claims.
Matched participants are linked to inpatient, outpatient, and
carrier files. The Medicare Provider Analysis and Review
(MedPAR) file contains claims for inpatient services covered
under Medicare Part A. The outpatient files contain claims for
services covered under Medicare Part B, including institutional
claims (Outpatient file) for outpatient services and noninstitutional
physician claims (Carrier file). Inpatient and outpatient CMS
claims have been available for research since 1991.
Study sample
ARIC cohort participants enrolled in fee-for-service (FFS)
Medicare, both Parts A and B, for at least 12 continuous months
between January 1, 1991, and December 31, 2009, were eligible
for inclusion (Figure 1). Fee-for-service enrollment was necessary
because Medicare Advantage insurance plans are not required to
submit claims for beneficiaries and those enrolled in only Part A
have incomplete claims data. Participants whose race was not
white or black and nonwhites from the Minneapolis and
Washington County field centers were excluded due to small
numbers. Those with missing or unreadable electrocardiograms
(ECG) or prevalent AF at the initial ARIC study exam were
excluded. In order to ascertain incident diagnoses, and remove
prevalent cases of AF, participants with AF diagnosed during the
first year of FFS enrollment, from either ARIC or CMS, were
excluded, as were those with AF diagnosed based on ARIC data
before January 1, 1992 because CMS data are available for
research beginning January 1, 1991. Participants enrolled in
Medicare due to disability or certain covered medical conditions
were not included in the study unless they met eligibility criteria
after becoming age eligible (aged $65 years) for Medicare
enrollment.
Definition of atrial fibrillation
Active ARIC follow-up identifies AF cases through three
sources: study visit ECGs, hospital discharge codes, and death
certificates [8]. AF cases obtained exclusively from study ECGs
(n = 4) were not included as AF events due to their subclinical
nature and to ensure consistent methods of ascertainment between
data sources. For this analysis, incident cases of AF were
ascertained from January 1, 1991, through December 31, 2009,
through two sources: hospital discharge codes, International
Classification of Diseases, 9th revision, (ICD-9) codes 427.3, 427.31 or
427.32, in any position, and death certificates with International
Classification of Diseases, 10th revision (ICD-10) code I48 or ICD-9
code 427.3x as the underlying cause of death. The AF incidence
date was defined as the date of first hospital discharge with an AF
diagnosis, or death by AF, whichever occurred earlier.
For MedPAR and outpatient CMS claims, incident AF was
defined as an AF discharge diagnosis (ICD-9 code 427.3, 427.31
or 427.32), in any position, on a single inpatient claim or as a
diagnostic code on two outpatient claims within 7–365 days. A
minimum of two outpatient claims at least 7 days apart were
required to reduce the likelihood of including ‘‘rule out’’ diagnoses
and to improve algorithm specificity [6,11]. The AF incidence
Cohort Follow-Up vs. Administrative Surveillance
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date was defined as the discharge date for a MedPAR short-stay
claim or the date of the second qualifying outpatient claim,
whichever occurred earlier. Secondary CMS AF definitions were
restricted to only MedPAR claims criteria and only outpatient
claims criteria.
Atrial fibrillation following cardiac operative procedures is fairly
common [12]; in both active ARIC follow-up and CMS
surveillance, an AF diagnosis occurring simultaneously with
cardiac revascularization (ICD-9 code 36.X) or other cardiac
surgery involving heart valves or septa (ICD-9 code 35.X) during
the index hospitalization, without a subsequent diagnosis of AF,
was not considered an AF diagnosis.
Assessment of covariates
During the baseline ARIC study exam (1987–1989), standard-
ized methods were used to collect data on age, race, sex,
educational achievement, cigarette smoking, ethanol consumption,
height, weight, blood pressure, antihypertensive medication use,
diabetes mellitus, total cholesterol, low-density lipoprotein choles-
terol, high-density lipoprotein cholesterol, triglycerides, and
previous myocardial infarction, heart failure or coronary heart
disease [10]. An ECG Cornell voltage score .28 mm in men or
.22 mm in women was considered evidence of left ventricular
hypertrophy [13]. Baseline age is age upon meeting enrollment
criteria for the present analysis. All other characteristics are from
the baseline ARIC study exam.
Statistical analysis
Person-years of follow-up were calculated as the date of study
eligibility, following 12 months of continuous enrollment in FFS
without an AF diagnosis, to the date of AF diagnosis, death, loss to
follow-up, cessation of FFS enrollment, or December 31, 2009,
whichever occurred earliest. Person-years of follow-up were
attributed to age- (5 year age groups), sex- and race- (whites and
blacks) specific groups. Age-, sex- and race-specific rates were
calculated dividing the number of incident AF cases by the
corresponding person-years of follow-up. Age- and sex-standard-
ized rates of incident AF for whites and blacks separately were
calculated using the sex and age (65–69 years, 70–74 years, 75–79
years and 80 years and older) person-time distribution of the
eligible cohort.
Concordance of incident AF events between data sources was
assessed with Cohen’s Kappa (K) statistic, a chance-adjusted
measure of agreement [14]. Percent agreement, overall, as well as
positive and negative agreement, were calculated [15–17].
A descriptive analysis, restricted to participants with incident AF
ascertained in both ARIC and CMS, and with complete covariate
data, was performed to determine the mean difference in incident
date. Linear regression, with time between diagnosis dates in
Figure 1. Flowchart of selection of study sample from the Atherosclerosis Risk in Communities Study. ARIC = Atherosclerosis Risk in
Communities. ECG = Electrocardiogram. Participants were excluded if they met one or more of the exclusion criterion.
doi:10.1371/journal.pone.0094321.g001
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ARIC and CMS, was used to determine predictors of earlier
diagnosis. Log-binomial regression, restricted to participants with
AF ascertained from at least one data source and with complete
covariate data, was used to identify demographic and clinical
factors associated with concordance. Age, sex and a composite
race and center variable were retained in the linear and log-
binomial regression models regardless of statistical significance.
Cox proportional hazards regression was used to determine the
association between established risk factors and incident AF based
exclusively on active ARIC follow-up; subsequently, cases of
incident AF ascertained only from surveillance of CMS data were
included to determine the impact of these additional events on the
associations. All statistical analyses were performed with SAS,
version 9.2 (SAS Institute, Cary, NC).
Results
Of the original 15,792 ARIC participants, our final sample
included 10,134 participants who were initially free of AF and
enrolled in FFS for at least 12 continuous months between January
1, 1991 and December 31, 2009. Notably, 18,194 person-years
available to ARIC had to be omitted because those participants
were in Medicare Advantage and therefore had incomplete CMS
claims (Figure 1). Active ARIC follow-up ascertained 831 incident
AF diagnoses during 76,754 person-years of follow-up. The
corresponding figures from combined inpatient and outpatient
CMS surveillance were 1,026 (considering inpatient and outpa-
tient ascertainment separately: 736 unique inpatient and 827
unique outpatient) AF diagnoses during a total of 75,596
(considering inpatient and outpatient follow-up separately:
76,887 inpatient and 76,293 outpatient) person-years of follow-
up. Baseline characteristics of the study sample stratified by source
of AF diagnosis are shown in Table 1. Overall, the mean age at
baseline, date of study eligibility, was 66.4 years (standard
deviation 1.5 years) and women accounted for slightly over half
and blacks for a quarter of the study sample. Among AF diagnoses
ascertained exclusively by active ARIC follow-up, 32% were
among blacks, while among those ascertained only in CMS
surveillance, 13% were among blacks. Participants with AF
diagnosed from both data sources had a higher prevalence of
prior myocardial infarction and heart failure compared to those
with AF ascertained from only one source.
The age-, sex- and race-specific incidence rates were slightly
higher based on CMS ascertainment of AF but followed a pattern
similar to the rates based on active ARIC follow-up (Figure 2).
Among participants with AF diagnosed in both data sources, 63%
had identical dates of AF diagnosis from ARIC and CMS and
nearly 75% had diagnoses within 630 days. Earlier ascertainment
of AF by one system versus the other was not associated with any
cardiovascular disease risk factors, after accounting for socio-
demographic factors. After accounting for differences in the age
and sex distribution of whites and blacks by standardizing the rates
to the study sample (Table 2), the AF incidence rate based on
ARIC ascertainment, per 1,000 person- years, was 11.4 (95%
confidence interval (CI): 10.5–12.2) and 8.6 (95% CI: 7.1–10.0)
among whites and blacks, respectively. The comparable rates from
CMS surveillance of AF were 14.8 (95% CI: 13.8–15.8) and 8.9
(95% CI: 7.5–10.4) for whites and blacks, respectively. Using
secondary CMS AF definitions, restricted to inpatient claims
criteria, the corresponding rates were 10.3 (95% CI: 9.5–11.1) and
6.6 (95% CI: 5.3–7.8), among whites and blacks, respectively;
restricted to outpatient claims criteria, the rates were 12.1 (95%
CI: 11.2–13.0) for whites and 6.4 (95% CI: 5.1–7.6) for blacks.
Utilizing the secondary CMS definition of AF, restricted to
inpatient claims criteria, among participants with AF diagnosed in
both sources, 90% of participants had AF diagnosed on the same
day and 93% were within 630 days. When considering only
outpatient claims criteria for CMS surveillance of AF compared to
active ARIC follow-up, among participants with AF diagnosed in
both sources, 61% of AF diagnoses occurred earlier in ARIC
(hospital discharge date) compared to outpatient CMS surveil-
lance.
Cohen’s K for concordance of incident AF diagnosis between
ARIC cohort follow-up and CMS data was 0.77 (95% CI: 0.75–
0.80) (Table 3). Comparing inpatient ascertainment of AF, the
primary method of AF detection in ARIC, the K statistic
improved to 0.85 (95% CI: 0.83–0.87). Race-specific K statistics
were similar to the overall sample estimates (not shown) except for
active ARIC follow-up versus CMS outpatient surveillance;
concordance was lower among blacks, 0.56 (95% CI: 0.48–0.63).
After accounting for age, sex and race/center, a descriptive
analysis did not identify any factors associated with concordance
between data sources.
To explore the impact of including incident AF cases
ascertained only in CMS surveillance data, an analysis of the
association between incident AF and the primary risk factors (age,
male sex, white race, BMI, hypertension, diabetes, current
smoking and prior heart disease) was performed. The beta
estimates were almost identical and not significantly different in
a model based exclusively on active ARIC follow-up methods
compared to a model with the addition of cases from CMS
surveillance (Table 4) suggesting the omission of CMS ascertained
(mostly outpatient) AF does not bias the associations derived from
active ARIC surveillance alone.
Discussion
In this community-based prospective study, AF incidence rates
were slightly lower based on active ARIC follow-up compared to
CMS surveillance. The rates by either method followed a similar
pattern, increasing with age and consistently higher among whites
and men compared to blacks and women, respectively. Concor-
dance of incident AF between data sources was very good, [14]
although 19% more AF cases were identified from CMS largely
due to outpatient ascertainment of AF. Furthermore, there
appeared to be little bias in associations based only on active
ARIC follow-up versus surveillance including CMS. To our
knowledge, this is the first study to compare AF rates as well as
concordance of diagnosis between data sources using only
inpatient, only outpatient, and combined inpatient and outpatient
data [7].
Reliance exclusively on active ARIC follow-up identified 831
incident cases of AF while CMS surveillance yielded 1,026
incident AF events. Concordance between the two data sources
was good with a K statistic of 0.77 (95% CI: 0.75–0.80). As
expected, because active ARIC follow-up relies exclusively on
inpatient claims to identify AF, concordance improved when
comparing only inpatient data. However, discrepancies persisted
between the two data sources. Potential reasons for the discrep-
ancies include that, among the 63 ARIC participants with AF
ascertained from inpatient CMS data but not ARIC data, some
participants stopped participating in annual telephone follow-up
for the ARIC study but continued to be followed by the ARIC
study for fatal events. Consequently, ARIC could not identify
hospitalizations for these participants occurring outside of the
geographic catchment area of the four ARIC communities.
Possible reasons AF was obtained in ARIC data but not in
CMS data include that the participant was admitted at a Veterans
Cohort Follow-Up vs. Administrative Surveillance
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Affairs Hospital where CMS does cover the stay and that ARIC
data captures up to 26 diagnosis and procedure codes while CMS
MedPAR records only include 10 diagnosis and 6 procedure
codes.
There are advantages and disadvantages of both active cohort
follow-up and CMS surveillance to identify incident AF. Advan-
tages of utilizing active cohort follow-up include ascertainment of
AF at younger ages (prior to Medicare eligibility) and ability to
identify AF regardless of type of insurance; disadvantages of this
approach include missing outpatient diagnoses of AF and reliance
on participants to report hospitalizations that occur outside of the
study catchment area. The benefits of CMS surveillance data
include detection of outpatient AF diagnoses and diagnoses for
participants who stopped participating in cohort follow-up;
disadvantages include lack of information on those ,65 years as
well as incomplete claims during Medicare Advantage enrollment.
Despite these opposing advantages and disadvantages, the
results from the two methods were similar with comparable
incidence rates, high concordance, and little evidence of bias of
associations between AF and risk factors. These results can be
interpreted several ways: supporting the exclusive use of active
cohort follow-up, providing caution about the completeness of
data from reliance on one method, and finding that two very
different methods of AF ascertainment yielded similar results.
This study has several limitations. Medicare Advantage plans
are not required to submit claims on their beneficiaries; a total of
18,194 person-years (19%) of follow-up were unobservable as a
result of HMO enrollment (all other eligibility criteria were met)
out of 97,740 total person-years. More importantly, person-years
missed varied by center (Forsyth County, NC: 7,935, Jackson, MS:
1,640, Minneapolis, MN: 7,985, and Washington County, MD:
634). This makes use of CMS alone impractical for ARIC follow-
up. Although exclusion of participants with Medicare Advantage
limits the generalizability of the study findings, the concordance
comparisons are applicable to the FFS population. ARIC involves
whites and blacks from only three and two communities,
respectively, and might not be generalizable to all whites and
blacks in the US. In active ARIC follow-up, AF ascertainment
relies primarily on hospital discharge codes and the diagnosis is not
otherwise validated. However, this method has been found to have
acceptable validity; in a sample of 125 hospital discharge
summaries with a first ICD-9 code for AF, 89% were confirmed
based on ECGs performed during that hospitalization [8]. Finally,
neither data source identified AF using a gold standard and
consequently high concordance between the two data sources
supports, but does not prove, validity of these approaches.
The present study also has several strengths. First, its large
sample size, with a substantial black population, and long follow-
up of study participants enabled race-specific calculations. Most
previous studies have been conducted in predominately white
populations which is a limitation because some measures of
validity, including PPV, are highly influenced by the prevalence of
the disease in the source population, and blacks are known to have
a lower risk of AF [8,18–20]. Second, only one prior study has
assessed the ability of administrative data, compared to physician
reviewed hospital discharge summaries with a first ICD-9 code for
Table 1. Baseline* (1987–89) characteristics of Atherosclerosis Risk in Communities participants enrolled in Medicare fee-for-










(n = 10,134) (n = 9015) (n = 93) (n = 288) (n = 738) p-value
Age, years 66.461.5 66.461.5 66.761.9 66.561.6 66.661.6 0.01
Women, % 57.0 58.5 46.2 42.4 45.4 ,0.0001
Black, % 26.0 27.2 32.3 13.2 15.3 ,0.0001
High school graduate, % 76.8 77.4 62.4 76.4 71.5 ,0.0001
Current smoker, % 23.2 22.6 30.1 22.2 29.3 0.0002
Current drinker, % 55.3 55.3 46.7 57.6 55.0 0.34
BMI (kg/m2) 27.765.2 27.665.2 28.865.6 28.165.1 28.665.4 ,0.0001
Hypertension, % 34.2 32.8 39.8 40.0 49.0 ,0.0001
Antihypertensive medication, % 25.0 23.8 25.0 31.9 37.1 ,0.0001
Diabetes mellitus, % 10.6 10.0 18.3 12.9 16.4 ,0.0001
Total cholesterol, mg/dL 216.6641.7 216.3641.6 220.8649.6 217.2645.4 219.3639.5 0.20
LDL-c, mg/dL 139.0639.2 138.5639.2 143.6647.4 141.8644.0 142.8635.6 0.01
HDL-c, mg/dL 52.1617.0 52.5617.1 49.1614.5 49.4616.4 47.7615.6 ,0.0001
Triglycerides, mg/dL 130.7685.3 129.0684.1 140.5671.5 136.26100.9 147.8692.0 ,0.0001
Left ventricular hypertrophy, % 1.8 1.6 2.2 2.9 3.7 0.0002
Previous myocardial infarction, % 3.4 2.8 3.2 6.6 9.5 ,0.0001
Heart failure, % 4.1 3.7 4.4 4.3 8.5 ,0.0001
Coronary heart disease, % 4.1 3.4 3.3 9.1 11.4 ,0.0001
*Baseline age is age upon meeting enrollment criteria for the present analysis. All other characteristics are from the initial ARIC study exam (1987–1989).
ARIC = Atherosclerosis Risk in Communities.
CMS = Centers for Medicare and Medicaid Services.
Continuous variables presented as mean 6 standard deviation (SD).
P-values from testing the null hypothesis of independence from chi-square (categorical) and F-test (continuous).
doi:10.1371/journal.pone.0094321.t001
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Figure 2. Age-, sex- and race-specific incidence rates of atrial fibrillation by source of diagnosis. CMS includes inpatient (MedPAR) or
outpatient diagnosis of atrial fibrillation. 1,000 p-y = 1,000 person-years. Vertical bars represent 95% confidence intervals. P-values from testing the
null hypothesis that the incidence rate ratio for each sex and race group (ARIC compared to CMS) equals one.
doi:10.1371/journal.pone.0094321.g002
Table 2. Race-specific incidence rates of atrial fibrillation among Atherosclerosis Risk in Communities participants enrolled in
Medicare fee-for-service by source of diagnosis.
Source of Diagnosis Whites (n = 7504) Blacks (n = 2630) p-value
ARIC Data
Incident AF (n/person-years) 688/58606.8 143/18146.7
Unadjusted incidence rate* 11.7 (10.9–12.7) 7.9 (6.7–9.3) ,0.0001
Age- and sex-standardized incidence rate* 11.4 (10.5–12.2) 8.6 (7.1–10.0) 0.003
All CMS Data{
Incident AF (n/person-years) 875/57528.8 151/18067.6
Unadjusted incidence rate* 15.2 (14.2–16.3) 8.4 (7.1–9.8) ,0.0001
Age- and sex-standardized incidence rate* 14.8 (13.8–15.8) 8.9 (7.5–10.4) ,0.0001
Inpatient (MedPAR) Data
Incident AF (n/person-years) 623/58677.7 113/18209.6
Unadjusted incidence rate* 10.6 (9.8–11.5) 6.2 (5.2–7.5) ,0.0001
Age- and sex-standardized incidence rate* 10.3 (9.5–11.1) 6.6 (5.3–7.8) ,0.0001
Outpatient CMS Data
Incident AF (n/person-years) 721/58094.2 106/18198.5
Unadjusted incidence rate* 12.4 (11.5–13.4) 5.8 (4.8–7.0) ,0.0001
Age- and sex-standardized incidence rate* 12.1 (11.2–13.0) 6.4 (5.1–7.6) ,0.0001
ARIC = Atherosclerosis Risk in Communities.
CMS = Centers for Medicare and Medicaid Services.
*Rates per 1,000 person-years (95% confidence intervals).
{Includes inpatient (MedPAR) and outpatient diagnosis of atrial fibrillation.
P-values from testing the null hypothesis that the incidence rate ratio (whites compared to blacks) equals one.
doi:10.1371/journal.pone.0094321.t002
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AF and ECGs, to identify incident AF events; the PPV for AF was
89% and for incident AF was 62% [8]. In the present study,
concordance of prevalent AF was similar to that of incident AF
diagnosis (data not shown). The ability to identify incident AF
events is especially important for comparative effectiveness
research, studies of healthcare utilization over the entire disease
course of AF, and drug safety surveillance; for example, a
comparative effectiveness research study might want to include
only treatment-naı̈ve participants in order to decrease biases
associated with treatment effectiveness in observational studies.
Third, claims data are limited with respect to clinical character-
istics since their primary purpose is for reimbursement. In this
study, the ARIC data were linked to CMS data and, as a result,
information not available in claims data, such as detailed and
validated demographic, behavioral and comorbid conditions
measured using standardized methodology, were present and
included in descriptive analyses.
Table 3. Overall concordance of incident atrial fibrillation diagnosis based on Atherosclerosis Risk in Communities data and
Centers for Medicare and Medicaid Services data.
All CMS* Inpatient (MedPAR) CMS Outpatient CMS
AF No AF Total AF No AF Total AF No AF Total
ARIC Cohort Follow-up AF 738 93 831 673 158 831 563 268 831
No AF 288 9015 9303 63 9240 9303 264 9039 9303
Total 1026 9108 10134 736 9398 10134 827 9307 10134
Kappa 95% confidence interval 0.77 (0.75–0.80) 0.85 (0.83–0.87) 0.65 (0.62–0.68)
% agreement 96 98 95
% positive agreement 66 75 51
% negative agreement 96 98 94
ARIC = Atherosclerosis Risk in Communities.
CMS = Centers for Medicare and Medicaid Services.
*All CMS includes MedPAR and outpatient claims.
Inpatient CMS includes MedPAR claims.
Outpatient CMS includes outpatient and carrier claims.
% agreement calculated as the number of participants with consistent classification of diagnosed AF from active ARIC cohort follow-up and surveillance of CMS divided
by the total number of observations and converted to a percent.
% positive agreement calculated as the number of participants classified as having AF based on both active ARIC cohort follow-up and surveillance of CMS, conditional
on being classified as having AF from at least one source, and converted to a percent.
% negative agreement calculated as the number of participants classified as not having AF based on both active ARIC cohort follow-up and surveillance of CMS,
conditional on being classified as not having AF from at least one source, and converted to a percent.
Data are limited to participants enrolled in Medicare fee-for-service.
doi:10.1371/journal.pone.0094321.t003
Table 4. Beta coefficients for the association of primary risk factors with incident atrial fibrillation (AF) using active Atherosclerosis
Risk in Communities (ARIC) follow-up compared to active ARIC follow-up plus surveillance of Centers for Medicare and Medicaid
Services (CMS) data.
Active ARIC Follow-Up
Active ARIC Follow-Up and CMS
Surveillance
Beta Coefficient Standard Error Beta Coefficient Standard Error p-value
Age, years 0.10 0.004 0.10 0.004 0.79
Female (Male) 20.45 0.05 20.47 0.04 0.75
Black (White) 20.53 0.06 20.57 0.06 0.70
BMI, kg/m2 0.05 0.005 0.04 0.004 0.79
Hypertensive (Normotensive) 0.40 0.05 0.38 0.05 0.83
Diabetic (Non diabetic) 0.43 0.06 0.41 0.06 0.78
Current smoker (Ever, never smoker) 0.63 0.05 0.59 0.05 0.58
Prior heart disease* (No prior heart disease) 0.67 0.07 0.67 0.06 0.96
Estimates correspond to log(hazard ratios) from Cox proportional hazards regression models.
ARIC = Atherosclerosis Risk in Communities.
CMS = Centers for Medicare and Medicaid Services.
Exposed (Referent).
*Prior heart disease defined as the presence of heart failure, myocardial infarction or coronary heart disease.
P-values from a one-degree-of-freedom Wald chi-square test of the null hypothesis that the beta coefficient from model one equals the beta coefficient from model
two.
doi:10.1371/journal.pone.0094321.t004
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In conclusion, this study provides support for the potential value
of utilizing multiple data sources to identify incident AF and
suggests the need for caution about completeness of each data
source. Nonetheless, two very different approaches to identifying
incident AF produced similar results. Each approach has unique
strengths and limitations and, when combined, could provide a
more complete picture of newly-diagnosed AF. Moving forward,
ARIC and similar studies should evaluate how to incorporate
Medicare and other administrative data in the ascertainment of
outcomes, factoring in the data limitations regarding coverage and
quality.
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